CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...

The National Institutes of Health has awarded an Oklahoma Medical Research Foundation scientist a $4.1 million grant to study ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

“Two chromosomal inversions of different sizes were induced using CRISPR/Cas9 to move heterochromatic ... professor at the Karlsruhe Institute of Technology and an author of the paper ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Similarly, in 2020, the prize went to developers of CRISPR, “genetic scissors” for editing DNA ... “We're addressing a significant component of the waste stream with this technology. That'd make a ...

CRISPR-Cas9 technology has the potential to enhance photosynthetic efficiency and increase crop yields. CRISPR-Cas9 is a gene editing process where genetic engineers can target specific genes in the ...